278
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study

, , , , , , , , , , , , , , , , , & show all
Pages 506-511 | Received 01 Nov 2014, Accepted 28 Jun 2015, Published online: 05 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jaime Luna, Philippe Couratier, Sanae Lahmadi, Géraldine Lautrette, Andrea Fontana, Rosanna Tortelli, Giancarlo Logroscino, Pierre-Marie Preux, Massimilano Copetti & Marin Benoit. (2021) Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 478-485.
Read now

Articles from other publishers (7)

Reza Boostani, Nahid Olfati, Hosein Shamshiri, Zanireh Salimi, Farzad Fatehi, Seyed Arya Hedjazi, Atefeh Fakharian, Majid Ghasemi, Ali Asghar Okhovat, Keivan Basiri, Bahram Haghi Ashtiani, Behnaz Ansari, Gholam Reza Raissi, Seyed Ahmadreza Khatoonabadi, Payam Sarraf, Sara Movahed, Akram Panahi, Bentolhoda Ziaadini, Mohammad Yazdchi, Jalal Bakhtiyari & Shahriar Nafissi. (2023) Iranian clinical practice guideline for amyotrophic lateral sclerosis. Frontiers in Neurology 14.
Crossref
Joshi Pranav B, Shah Shalin D, Sikariya Kusum K, Chaudhary Jay & Patel Mayank A. (2021) CLINICAL CHARACTERISTICS OF MOTOR NEURON DISEASE : A SINGLE CENTRE DATA FROM GUJARAT STATE.. GLOBAL JOURNAL FOR RESEARCH ANALYSIS, pages 9-11.
Crossref
Alex G. Karanevich, Luke J. Weisbrod, Omar Jawdat, Richard J. Barohn, Byron J. Gajewski, Jianghua He & Jeffrey M. Statland. (2018) Using automated electronic medical record data extraction to model ALS survival and progression. BMC Neurology 18:1.
Crossref
Alex G. Karanevich, Jeffrey M. Statland, Byron J. Gajewski & Jianghua He. (2018) Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression. BMC Medical Research Methodology 18:1.
Crossref
Mona Ahmadi, Elmira Agah, Shahriar Nafissi, Mahmoud Reza Jaafari, Mohammad Hossein Harirchian, Payam Sarraf, Sara Faghihi-Kashani, Seyed Jalal Hosseini, Abdolreza Ghoreishi, Vajiheh Aghamollaii, Mostafa Hosseini & Abbas Tafakhori. (2018) Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial. Neurotherapeutics 15:2, pages 430-438.
Crossref
Hosein Shamshiri, Farzad Fatehi, Roya Abolfazli, Mohammad Hossein Harirchian, Behnaz Sedighi, Babak Zamani, Ali Roudbari, Nazanin Razazian, Fatemeh Khamseh & Shahriar Nafissi. (2016) Trends of quality of life changes in amyotrophic lateral sclerosis patients. Journal of the Neurological Sciences 368, pages 35-40.
Crossref
N Shahrizaila, G Sobue, S Kuwabara, S H Kim, Carol Birks, D S Fan, J S Bae, C J Hu, M Gourie-Devi, Y Noto, K Shibuya, K J Goh, R Kaji, CP Tsai, L Cui, P Talman, R D Henderson, S Vucic & M C Kiernan. (2016) Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. Journal of Neurology, Neurosurgery & Psychiatry 87:8, pages 821-830.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.